cathepsin S
CTSSproteinCathepsin S is a macrophage lysosomal protease that degrades fibrous-cap extracellular matrix in atherosclerosis.
Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencemedium
RationaleLysosomal protease in macrophages; ECM degradation in atherosclerosis and aortic disease.
Also acts inVascular inflammation, Systemic / off-pathway
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000163131
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I43
C — confounder / Type-II58
A — assay feasibility72
E — evidence strength23
T1DI (composite)7
Specificity differential (R−C)-14.3
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(3)
- Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.Journal of thrombosis and thrombolysis · 2021 · PMID 34708315 · doi
- Cysteinyl cathepsins in cardiovascular diseases.Biochimica et biophysica acta. Proteins and proteomics · 2020 · PMID 31926332 · doi
- Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice.Annals of biomedical engineering · 2012 · PMID 23180031 · doi